142 related articles for article (PubMed ID: 25586241)
1. Prognostic Value of Hepatocyte Growth Factor Receptor Expression in Patients with Perihilar Cholangiocarcinoma.
Watanabe H; Yokoyama Y; Kokuryo T; Ebata T; Igami T; Sugawara G; Mizuno T; Shimoyama Y; Nagino M
Ann Surg Oncol; 2015 Jul; 22(7):2235-42. PubMed ID: 25586241
[TBL] [Abstract][Full Text] [Related]
2. The Complete Loss of Tyrosine Kinase Receptors MET and RON Is a Poor Prognostic Factor in Patients with Extrahepatic Cholangiocarcinoma.
Hayashi Y; Yamaguchi J; Kokuryo T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Nagino M
Anticancer Res; 2016 Dec; 36(12):6585-6592. PubMed ID: 27919987
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of RON and MET receptor coexpression in patients with colorectal cancer.
Lee CT; Chow NH; Su PF; Lin SC; Lin PC; Lee JC
Dis Colon Rectum; 2008 Aug; 51(8):1268-74. PubMed ID: 18536971
[TBL] [Abstract][Full Text] [Related]
4. Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma.
Oguro S; Esaki M; Kishi Y; Nara S; Shimada K; Ojima H; Kosuge T
Ann Surg Oncol; 2015; 22(6):1915-24. PubMed ID: 25404474
[TBL] [Abstract][Full Text] [Related]
5. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
[TBL] [Abstract][Full Text] [Related]
6. Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in Klatskin tumor patients.
Lederer A; Herrmann P; Seehofer D; Dietel M; Pratschke J; Schlag P; Stein U
Hepatology; 2015 Sep; 62(3):841-50. PubMed ID: 25953673
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder.
Cheng HL; Liu HS; Lin YJ; Chen HH; Hsu PY; Chang TY; Ho CL; Tzai TS; Chow NH
Br J Cancer; 2005 May; 92(10):1906-14. PubMed ID: 15870710
[TBL] [Abstract][Full Text] [Related]
8. [Klatskin tumor: long-term survival following surgery].
Juntermanns B; Fingas CD; Sotiropoulos GC; Jaradat D; Dechêne A; Reis H; Kasper S; Paul A; Kaiser GM
Chirurg; 2016 Jun; 87(6):514-9. PubMed ID: 27090415
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma.
Buettner S; van Vugt JL; Gani F; Groot Koerkamp B; Margonis GA; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Guglielmi A; IJzermans JN; Pawlik TM
J Gastrointest Surg; 2016 Oct; 20(10):1716-24. PubMed ID: 27412318
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Prdx1 in hilar cholangiocarcinoma: a predictor for recurrence and prognosis.
Zhou J; Shen W; He X; Qian J; Liu S; Yu G
Int J Clin Exp Pathol; 2015; 8(9):9863-74. PubMed ID: 26617696
[TBL] [Abstract][Full Text] [Related]
11. Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma.
Zhang TJ; Xue D; Zhang CD; Zhang ZD; Liu QR; Wang JQ
World J Gastroenterol; 2017 Apr; 23(13):2318-2329. PubMed ID: 28428711
[TBL] [Abstract][Full Text] [Related]
12. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.
Noji T; Tsuchikawa T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Shichinohe T; Hirano S
J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):442-8. PubMed ID: 27207604
[TBL] [Abstract][Full Text] [Related]
13. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection.
Groot Koerkamp B; Wiggers JK; Allen PJ; Besselink MG; Blumgart LH; Busch OR; Coelen RJ; D'Angelica MI; DeMatteo RP; Gouma DJ; Kingham TP; Jarnagin WR; van Gulik TM
J Am Coll Surg; 2015 Dec; 221(6):1041-9. PubMed ID: 26454735
[TBL] [Abstract][Full Text] [Related]
14. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract.
Compérat E; Roupret M; Chartier-Kastler E; Bitker MO; Richard F; Camparo P; Capron F; Cussenot O
J Urol; 2008 Mar; 179(3):868-72; discussion 872. PubMed ID: 18221954
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of the site of portal vein invasion in patients with surgically resected perihilar cholangiocarcinoma.
Nakanishi Y; Tsuchikawa T; Okamura K; Nakamura T; Tamoto E; Murakami S; Ebihara Y; Kurashima Y; Noji T; Asano T; Shichinohe T; Hirano S
Surgery; 2016 Jun; 159(6):1511-1519. PubMed ID: 26948498
[TBL] [Abstract][Full Text] [Related]
18. Development and external validation of a nomogram for predicting the effect of tumor size on survival of patients with perihilar cholangiocarcinoma.
Zhang Y; Wu Z; Wang X; Li C; Chang J; Jiang W; Wang H; Wang Y; Li X
BMC Cancer; 2020 Oct; 20(1):1044. PubMed ID: 33126868
[TBL] [Abstract][Full Text] [Related]
19. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.
Aoba T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y; Nagino M
Ann Surg; 2013 Apr; 257(4):718-25. PubMed ID: 23407295
[TBL] [Abstract][Full Text] [Related]
20. Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar Cholangiocarcinoma.
Li C; Li X; Wu L; Jiang Z
Technol Cancer Res Treat; 2017 Aug; 16(4):421-427. PubMed ID: 27143047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
